Despite mast cell tumors representing a spectrum of tumors that vary dramatically in prognosis from near-benign to very malignant, historically we have applied similar aggressive diagnostic and therapeutic approaches to all types. This session serves to help the practitioner differentiate the prognostic categories and determine when and when not to be aggressive.
Support and Resource
Recorded at the NAVC Conference 2013.
This module contains a video recording of the lecture and a range of self-assessment questions leading to a printable certificate.